ATE412891T1 - Verbessertes toxizität-screening verfahren - Google Patents

Verbessertes toxizität-screening verfahren

Info

Publication number
ATE412891T1
ATE412891T1 AT00965025T AT00965025T ATE412891T1 AT E412891 T1 ATE412891 T1 AT E412891T1 AT 00965025 T AT00965025 T AT 00965025T AT 00965025 T AT00965025 T AT 00965025T AT E412891 T1 ATE412891 T1 AT E412891T1
Authority
AT
Austria
Prior art keywords
screening procedures
toxicity screening
improved toxicity
predicting
cytotoxicity
Prior art date
Application number
AT00965025T
Other languages
English (en)
Inventor
James Mckim
Gary Cockerell
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE412891T1 publication Critical patent/ATE412891T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Paper (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00965025T 1999-09-27 2000-09-14 Verbessertes toxizität-screening verfahren ATE412891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15620699P 1999-09-27 1999-09-27
US09/586,242 US6998249B1 (en) 1999-09-27 2000-06-02 Toxicity screening method

Publications (1)

Publication Number Publication Date
ATE412891T1 true ATE412891T1 (de) 2008-11-15

Family

ID=26852966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965025T ATE412891T1 (de) 1999-09-27 2000-09-14 Verbessertes toxizität-screening verfahren

Country Status (11)

Country Link
US (1) US6998249B1 (de)
EP (1) EP1218737B1 (de)
JP (1) JP2003510093A (de)
KR (1) KR20020048418A (de)
AT (1) ATE412891T1 (de)
AU (1) AU778295B2 (de)
CA (1) CA2383987A1 (de)
DE (1) DE60040677D1 (de)
MX (1) MXPA02003147A (de)
NZ (1) NZ517798A (de)
WO (1) WO2001023886A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7415358B2 (en) 2001-05-22 2008-08-19 Ocimum Biosolutions, Inc. Molecular toxicology modeling
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
WO2005047482A2 (en) * 2003-11-12 2005-05-26 Xiao Xu Real time electronic cell sensing systems and applications for cell-based assays
US8263375B2 (en) 2002-12-20 2012-09-11 Acea Biosciences Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
US10539523B2 (en) 2002-12-20 2020-01-21 Acea Biosciences, Inc. System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties
US10551371B2 (en) 2003-11-10 2020-02-04 Acea Biosciences, Inc. System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function
US11346797B2 (en) 2002-12-20 2022-05-31 Agilent Technologies, Inc. System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties
US10215748B2 (en) 2002-12-20 2019-02-26 Acea Biosciences, Inc. Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
CN101331500B (zh) 2005-10-14 2015-04-29 尤尼森斯繁殖技术公司 细胞群的变化的测定
WO2008010843A2 (en) * 2005-12-09 2008-01-24 The Regents Of The University Of California Assessing the toxic potential of nanomaterials
US7615361B2 (en) * 2006-03-06 2009-11-10 Ceetox, Inc. Toxicity screening methods
CA2665183A1 (en) * 2006-10-02 2008-04-10 Cellartis Ab Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
FR2908310B1 (fr) * 2006-11-14 2009-07-10 Phytodia Produits agonistes de tgr5 et leurs applications
DK2173853T3 (da) 2007-06-29 2011-07-04 Unisense Fertilitech As Indretning, system og fremgangsmåde til at overvåge og/eller dyrke mikroskopiske objekter
CA2714183A1 (en) * 2008-02-14 2009-08-20 F. Hoffmann-La Roche Ag Prediction of bone marrow toxicity
WO2009137440A1 (en) 2008-05-05 2009-11-12 Acea Biosciences, Inc. Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
EP2294412A1 (de) * 2008-06-04 2011-03-16 Ceetox Inc. Verfahren zur vorhersage der hautsensibilisierungswirkung von verbindungen
US20110004414A1 (en) * 2009-06-06 2011-01-06 Ceetox, Inc. Method for Predicting Respiratory Toxicity of Compounds
GB0911060D0 (en) 2009-06-26 2009-08-12 Ge Healthcare Uk Ltd Methods for predicting the toxicity of a chemical
WO2011146531A1 (en) 2010-05-18 2011-11-24 Acea Biosciences, Inc Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments
US20120179381A1 (en) * 2010-06-17 2012-07-12 Mckim James M Toxicity screening methods
EP2574924A1 (de) * 2011-09-28 2013-04-03 Merck Patent GmbH Verfahren zur Bestimmung des Status von Zellen
US10852296B2 (en) * 2011-12-27 2020-12-01 BiOMICom Incorporated Micro-sampling for cell, tissue, and micro-organism monitoring
WO2015106066A1 (en) * 2014-01-11 2015-07-16 The J. David Gladstone Instututes In vitro assays for inhibition of microglial activation
SG11201705495XA (en) * 2014-01-14 2017-08-30 Asedasciences Ag Identification of functional cell states
US12066428B2 (en) 2015-11-20 2024-08-20 Agilent Technologies, Inc. Cell-substrate impedance monitoring of cancer cells
SE540775C2 (en) * 2016-03-21 2018-11-06 Microfluidic device for culturing cells
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
US11746328B2 (en) 2017-03-03 2023-09-05 Agilent Technologies, Inc. Methods and systems for functional maturation of iPSC and ESC derived cardiomyocytes
JP7394367B2 (ja) 2018-06-28 2023-12-08 ダイキン工業株式会社 気体の細胞毒性評価方法
WO2020022413A1 (ja) 2018-07-25 2020-01-30 ダイキン工業株式会社 ガス濃度予測方法
USD941488S1 (en) 2020-02-07 2022-01-18 Agilent Technologies, Inc. Instrument for analyzing biological cells
US20210301245A1 (en) 2020-03-29 2021-09-30 Agilent Technologies, Inc. Systems and methods for electronically and optically monitoring biological samples
US12559784B2 (en) 2023-02-24 2026-02-24 Lebrun Labs Llc In chemico test for toxicity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62879A (en) 1981-05-15 1985-09-29 Chaya Moroz Monoclonal antibodies,clones producing them,preparation of such antibodies and clones and cytotoxic and immunoassay using such antibodies
US4532751B1 (en) 1984-04-16 1998-02-03 Mayer Oskar Foods Automatic sheet product line
GB9221664D0 (en) 1992-10-15 1992-11-25 Shiny Chemical Ind Co Limited Propylene glycol monomethyl ether propionate and the process for the preparation thereof
WO1995032184A1 (en) 1994-05-23 1995-11-30 Arqule, Inc. Systematic modular production of aminimide- and oxazolone- based molecules having at least two structural diversity elements
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
AU3577997A (en) 1996-06-24 1998-01-14 Irori Solid phase tyrphostin library linked to matrices with memories

Also Published As

Publication number Publication date
WO2001023886A1 (en) 2001-04-05
JP2003510093A (ja) 2003-03-18
CA2383987A1 (en) 2001-04-05
EP1218737A1 (de) 2002-07-03
NZ517798A (en) 2004-03-26
MXPA02003147A (es) 2002-09-30
US6998249B1 (en) 2006-02-14
AU7581600A (en) 2001-04-30
DE60040677D1 (de) 2008-12-11
WO2001023886A9 (en) 2002-11-21
AU778295B2 (en) 2004-11-25
KR20020048418A (ko) 2002-06-22
EP1218737B1 (de) 2008-10-29

Similar Documents

Publication Publication Date Title
DE60040677D1 (de) Verbessertes toxizität-screening verfahren
DK1207904T3 (da) Nye kliniske parametre til bestemmelse af hæmatologisk toksicitet forud for radioimmunterapi
TR200002445T2 (tr) Fosfolipaz inhibitörleri.
ATE37375T1 (de) Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva.
ECSP045255A (es) Cumarinas utiles como biomarcadores
AU7709198A (en) Low background multi-well plates for fluorescence measurements of biological andbiochemical samples
DE69928655D1 (de) Substituierte porphyrine
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
EP1141412A4 (de) Verfahren zur voraussage einer wirkstoffwechselwirkung unter verwendung biologischer response-profile
NO982826D0 (no) Radaranalyse
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
EP1276491A4 (de) Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung
DE69828080D1 (de) Pyrimidinderivate als markierte bindungspartner
DE59902179D1 (de) Elektrochemische synthese von perfluoralkylfluorophosphoranen
DE69939367D1 (de) G protein-verwandte kinasemutanten in der essentiellen hypertonie
AU2002309998A1 (en) Electrochemical method for high-throughput screening of minute quantities of candidate compounds
DK1348124T3 (da) Identifikation af individuelle celler under kinetiske assays
AU6015098A (en) Method of screening agents as candidates for drugs or sources of drugs
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
EA200100854A1 (ru) Кальций-литические соединения
EA200000522A1 (ru) 5-htагонисты
DE69913533D1 (de) Reagentien für cyp2d fluoreszenztest
ATE469238T1 (de) Verwendung von fluor-nmr zum screening mit hohem durchsatz
EA200500878A1 (ru) Кальцилитические соединения
MXPA05010062A (es) Metodo de deteccion selectiva de ligandos objetivo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties